Cytek Biosciences, Inc. (CTKB) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

CT

CTKB

Market Closed

Cytek Biosciences, Inc.

US

663 employees

CEO: Wenbin Jiang

Founded: 2021

$4.02

+$0.00(+NaN%)

Market Cap

519.15M

Beta

1.19

52W Range

N/A

Dividend Yield

0.00%

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Loading financial data for CTKB...

Explore CTKB

Key metrics and AI-powered insights

Price targets and earnings estimates

Income, balance sheet and cash flow

P/E, DCF and valuation multiples

Institutional and insider holdings

Analyst ratings and news sentiment

CTKB in the Healthcare

Small Cap

Browse sector stocks →

Browse industry stocks →